Novartis

Novartis has been ranked Tier 1 in the 2026 CCLA Corporate Mental Health Benchmark, the highest rating in the assessment of how listed companies manage and support workplace mental health. The Swiss pharmaceutical company announced the result, positioning itself among the leading global employers on corporate mental health standards and accountability.